Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.7499
-0.0422 (-5.33%)
Jul 29, 2026, 11:17 AM EDT - Market open
Oncolytics Biotech Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Oncolytics Biotech stock has a consensus rating of "Buy" and an average price target of $5.05. The average 1-year stock price forecast is 573.42% higher than the current stock price, while the lowest is $2.87 (+282.72%) and the highest is $10.02 (+1,236.18%).
Price Target: $5.05 (+573.42%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Oncolytics Biotech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jul 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $10 | Buy | Reiterates | $10 | +1,233.51% | Jul 13, 2026 |
| Lake Street | Lake Street | Buy Maintains $5 | Buy | Maintains | $5 | +566.76% | Jun 1, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $3 | Buy | Reiterates | $3 | +300.05% | May 21, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.24
from -0.30
EPS Next Year
-0.24
from -0.24
EPS and Forward PE are based on non-GAAP adjusted numbers.